Publication | Open Access
Keynote-407 China Extension study: Pembrolizumab (pembro) plus chemotherapy in Chinese patients with metastatic squamous NSCLC
19
Citations
0
References
2019
Year
MedicineMetastatic Squamous NsclcImmune Checkpoint InhibitorPharmacotherapyCancer TreatmentOncologyRadiation OncologyLung CancerChinese Patients
No additional data available for this publication yet. Check back later!